Clinical Trials Directory

Trials / Unknown

UnknownNCT05249894

Evaluation of Infective Risk, Efficacy of Bacterial Prophylaxis and Validation of Sepsis Scores NEWS (National Early Warning Score) and qSOFA (Quick Sequential Organ Failure Assessment) in Patient With Acute Myeloid Leukemia Treated With Intensive Chemotherapy

Evaluation of Infective Risk, Efficacy of Bacterial Prophylaxis and Validation of Sepsis Scores NEWS (National Early Warning Score) and qSOFA (Quick Sequential Organ Failure Assessment) in Patient With Acute Myeloid Leukemia Treated With Intensive Chemotherapy (LAM-SEPSIS)

Status
Unknown
Phase
Study type
Observational
Enrollment
400 (estimated)
Sponsor
A.O.U. Città della Salute e della Scienza · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Evaluation of Infective Risk, Efficacy of Bacterial Prophylaxis and Validation of sepsis scores NEWS (National Early Warning Score) and qSOFA (Quick Sequential Organ Failure Assessment) in Patient With Acute Myeloid Leukemia Treated With Intensive Chemotherapy

Conditions

Timeline

Start date
2022-03-23
Primary completion
2022-09-01
Completion
2022-09-01
First posted
2022-02-22
Last updated
2022-03-28

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05249894. Inclusion in this directory is not an endorsement.

Evaluation of Infective Risk, Efficacy of Bacterial Prophylaxis and Validation of Sepsis Scores NEWS (National Early War (NCT05249894) · Clinical Trials Directory